Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
106M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
617K
-
Shares change
-
+161K
-
Total reported value, excl. options
-
$1.63M
-
Value change
-
+$397K
-
Number of buys
-
5
-
Number of sells
-
-8
-
Price
-
$2.65
Significant Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) as of Q3 2020
15 filings reported holding SLS - SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share as of Q3 2020.
SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 617K shares
of 106M outstanding shares and own 0.58% of the company stock.
Largest 10 shareholders include Worth Venture Partners, LLC (214K shares), VANGUARD GROUP INC (135K shares), BlackRock Inc. (100K shares), GEODE CAPITAL MANAGEMENT, LLC (60.9K shares), Equitable Holdings, Inc. (60.3K shares), Bank of New York Mellon Corp (16.1K shares), DIMENSIONAL FUND ADVISORS LP (15.4K shares), MML INVESTORS SERVICES, LLC (11K shares), MORGAN STANLEY (2.84K shares), and Tower Research Capital LLC (TRC) (460 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.